|
|
|
|
|
| May 12,
2011 | ISSUE NUMBER 199 VOL 8 |
Regulatory
Outrage Over Drug Prices
KV Pharmaceuticals stirs up controversy by jacking up the price of its injectable progesterone to $1,500 a shot ...Read more
Educational Video
Improving Clinical Operations with Digital Signatures
The majority of large CROs and Pharmas are using digital signatures to speed clinical site initiation, reduce site monitoring reporting costs, and improve audit efficiency.  Watch this short video to learn how digital signatures enable these benefits and others
|
Treatments
Shrinks Prefer Latuda to Competition
A survey finds that psychiatrists are more likely to recommend Sunovion Pharmaceuticals’ Latuda to colleagues than Merck’s Saphris or Novartis’ Fenapt ...Read more
Advertisement
CBI’s 2nd Forum on Social Media Regulations and Compliance — June 21-22, 2011, Alexandria, VA
Your social media efforts cannot wait for DDMAC to issue guidance. Attend the social media event of the year and hear regulatory, marketing, compliance, legal and medical perspectives from BMS, Endo, J&J, Lilly, Merck, Par, Strativa and more! Register by May 27th at  www.cbinet.com/socialmedia and save $400 with priority code FXE796. |
Ethics
Allergan to Pay Journalists To Discuss Botox
It seems physicians aren’t the only ones getting paid to attend industry-sponsored events heavy on product discussions ...Read more
Global
Is the UK Losing Its Pharma Mojo?
Pfizer’s decision to close down it Sandwich, UK, site earlier this year could have marked the start of a mass exodus ...Read more
|
|
|
 // Ellen R. Strahlman, MD, MHSc, Senior Vice President and Chief Medical Officer of GlaxoSmithKline, was honored with a Visionary Award by the Foundation Fighting Blindness (Philadelphia), a national nonprofit that drives blindness research, on May 10. // Roche Partnering’s Susan Graf, N.J., Global Head of Strategic Evaluation and Due Diligence, was honored as a 2011 Rising Star by the Healthcare Businesswomen’s Association (HBA); and Roche employees Maria Fuentes, Ph.D., Director, Respiratory Drug Discovery; and Maryann Szabo, R.N., Director, U.S. Affiliate Regional Monitoring Network, were recognized for their significant contributions to industry in New Jersey at the 37th Annual TWIN Awards Dinner last week. //
Patheon (Toronto) appointed Michael E. Litton as Executive Vice President, Corporate Development and Strategy and General Counsel. //
Catalent Pharma Solutions (Somerset, NJ) announced the appointment of Harry Jeffreys as Vice President, Quality Management Systems & Compliance. // Aileron Therapeutics (Cambridge, Mass.) announced the appointments of three veterans of the life sciences industry and Wall Street to its Board of Directors. They are Julian Adams, Ph.D., President, Research & Development, Infinity Pharmaceuticals; Scott Kapnick, Managing Partner and Member of the Board of Highbridge Capital Management, and CEO of Highbridge Principal Strategies; and John H. McArthur, Dean Emeritus and the George Fisher Baker Professor of Business Administration Emeritus at Harvard Business School. // |
|
|
|
|
|
 |
|
|
| |
|
 |
|
 |
| In which area do you think new technology will have the greatest impact in the coming years? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
